Literature DB >> 6798613

Antiemetic effect of haloperidol in the dog as related to plasma level and dose.

C J Niemegeers, J J Heykants, P A Janssen.   

Abstract

A positive and highly significant correlation was found between SC dose, plasma concentration, and antiemetic effect of haloperidol in the dog. To protect dogs from apomorphine-induced emesis, a concentration of 1 ng haloperidol/ml plasma was always sufficient, whereas protection from emesis was never obtained with plasma levels lower than 0.53 ng/ml. The elimination rate of haloperidol from plasma varied from 1.53 to 2.60 among different animals. Thus, the interindividual variability to haloperidol was surprisingly low. Antiemetic effect and plasma elimination of haloperidol were not related to body weight.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798613     DOI: 10.1007/BF00432431

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Double-blind evaluation of haloperidol for antiemetic activity.

Authors:  F J Tornetta
Journal:  Anesth Analg       Date:  1972 Nov-Dec       Impact factor: 5.108

2.  The use of haloperidol for treatment of postoperative nausea and vomiting--a double-blind placebo-controlled trial.

Authors:  M D Barton; M Libonati; P J Cohen
Journal:  Anesthesiology       Date:  1975-04       Impact factor: 7.892

3.  Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients.

Authors:  R Rimón; I Averbuch; P Rozick; L Fijman-Danilovich; T Kara; H Dasberg; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.

Authors:  N Bjørndal; M Bjerre; J Gerlach; P Kristjansen; G Magelund; I H Oestrich; J Waehrens
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

5.  Low-dose haloperidol as antiemetic treatment in gastrointestinal disorders: a double-blind study.

Authors:  R S Christman; R A Weinstein; J B Larose
Journal:  Curr Ther Res Clin Exp       Date:  1974-11

6.  Haloperidol parenterally for treatment of vomiting and nausea from gastrointestinal disorders in a group of geriatric patients: double-blind, placebo-controlled study.

Authors:  E L Robbins; J D Nagel
Journal:  J Am Geriatr Soc       Date:  1975-01       Impact factor: 5.562

7.  [Apropos of vomiting in pregnancy: therapeutic study of R 1625].

Authors:  P Magnier
Journal:  Gynecol Prat       Date:  1964

8.  Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting.

Authors:  A J Reyntjens; C J Niemegeers; J M Van Nueten; P Laduron; J Heykants; K H Schellekens; R Marsboom; A Jageneau; A Broekaert; P A Janssen
Journal:  Arzneimittelforschung       Date:  1978

9.  Radioimmunoassay of bromperidol and haloperidol in human and canine plasma.

Authors:  E Van Den Eeckhout; F M Belpaire; M G Bogaert; P De Moerloose
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

10.  Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.

Authors:  V A Rao; M Bishop; A Coppen
Journal:  Br J Psychiatry       Date:  1980-12       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.